Analyze Diet

Resolution of sustained narrow complex ventricular tachycardia and tachycardia-induced cardiomyopathy in a Quarter Horse following quinidine therapy.

Abstract: Sustained narrow-QRS tachycardia of three months duration and left ventricular systolic dysfunction were identified in a fifteen-year-old Quarter Horse. No underlying cause for the tachyarrhythmia was found and no predisposing structural cardiac lesions were evident by echocardiography. Intravenous diltiazem and lidocaine were administered without achieving successful conversion of the arrhythmia. Oral quinidine therapy converted the tachyarrhythmia to sinus rhythm. Ventricular systolic dysfunction and chamber dilatation subsequently resolved. As with other species, echocardiographic features of dilated cardiomyopathy can be tachycardia-induced and may resolve following successful control of heart rate and rhythm.
Publication Date: 2012-07-26 PubMed ID: 22841902DOI: 10.1016/j.jvc.2012.05.004Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on a case where a fifteen-year-old Quarter Horse suffering from sustained narrow-QRS tachycardia and left ventricular systolic dysfunction was successfully treated using quinidine therapy, after initial attempts with intravenous diltiazem and lidocaine failed. The study demonstrates the potential of the rhythm-control drug quinidine in resolving such heart conditions in horses.

Details of the Case

  • A fifteen-year-old Quarter Horse was diagnosed with a sustained form of narrow QRS tachycardia, a specific type of abnormal heart rhythm, and left ventricular systolic dysfunction, a condition where the heart’s main pumping chamber is unable to contract forcefully.
  • This condition had been present for three months, and no structural cardiac anomalies or underlying causes for the tachyarrhythmia were evident by echocardiography, a diagnostic tool that uses sound waves to produce images of the heart.

Initial Treatment

  • The initial course of treatment involved the administration of intravenous diltiazem and lidocaine, both medications commonly used to control heart rate and stabilize heart rhythm.
  • However, the medications did not lead to successful conversion, implying that they were not effective in restoring the horse’s heartbeat to a normal rate and rhythm.

Quinidine Therapy

  • Subsequently, the horse was treated with quinidine, an oral medication more commonly used in human cases for the treatment of certain types of heart rhythm disorders.
  • This therapy successfully converted the horse’s tachyarrhythmia, indicating that it was effective in restoring a regular heart rhythm.

Outcome and Interpretation

  • Following the successful treatment, the ventricular systolic dysfunction and enlargement of the heart chambers were resolved.
  • This shows the potential of quinidine as a successful treatment for similar cardiac issues in horses where other medications are ineffective.
  • The researchers assert that, as with other species, echocardiographic features of dilated cardiomyopathy (heart muscle disease) in horses may be induced by tachycardia and could potentially be resolved following successful control of heart rate and rhythm.

Cite This Article

APA
Stern JA, Doreste YR, Barnett S, Lahmers SM, Baumwart RD, Seino KK, Bonagura JD. (2012). Resolution of sustained narrow complex ventricular tachycardia and tachycardia-induced cardiomyopathy in a Quarter Horse following quinidine therapy. J Vet Cardiol, 14(3), 445-451. https://doi.org/10.1016/j.jvc.2012.05.004

Publication

ISSN: 1875-0834
NlmUniqueID: 101163270
Country: Netherlands
Language: English
Volume: 14
Issue: 3
Pages: 445-451

Researcher Affiliations

Stern, Joshua A
  • North Carolina State University, 1052 William Moore Drive, Raleigh, NC 27607, USA. jsterndvm@gmail.com
Doreste, Yamir R
    Barnett, Susan
      Lahmers, Sunshine M
        Baumwart, Ryan D
          Seino, Kathy K
            Bonagura, John D

              MeSH Terms

              • Animals
              • Anti-Arrhythmia Agents / therapeutic use
              • Horse Diseases / drug therapy
              • Horses
              • Male
              • Quinidine / therapeutic use
              • Tachycardia, Ventricular / classification
              • Tachycardia, Ventricular / drug therapy
              • Tachycardia, Ventricular / veterinary

              Citations

              This article has been cited 0 times.